Combination index values for effects of fludarabine and nutlin-3 on cell viability
Patient no. . | ED50 . | ED75 . | ED90 . | Averaged CI* . |
---|---|---|---|---|
1 | 0.32 | 0.63 | 1.24 | 0.73 |
7 | 0.99 | 0.98 | 0.86 | 0.94 |
13 | 0.42 | 1.02 | 2.08 | 1.17 |
14 | 0.63 | 0.59 | 0.67 | 0.63 |
16 | 1.09 | 1.06 | 1.20 | 1.12 |
17 | 0.54 | 1.50 | 2.15 | 1.40 |
19 | 0.90 | 0.63 | 0.44 | 0.66 |
20 | 0.52 | 0.25 | 0.34 | 0.37 |
21 | 0.44 | 0.58 | 0.80 | 0.61 |
22 | 0.90 | 0.65 | 0.42 | 0.66 |
24 | 0.90 | 0.75 | 0.65 | 0.77 |
25 | 0.67 | 0.57 | 0.57 | 0.60 |
26 | 1.12 | 1.01 | 0.99 | 1.04 |
28 | 0.60 | 0.81 | 0.88 | 0.76 |
29 | 0.88 | 0.92 | 0.95 | 0.92 |
Patient no. . | ED50 . | ED75 . | ED90 . | Averaged CI* . |
---|---|---|---|---|
1 | 0.32 | 0.63 | 1.24 | 0.73 |
7 | 0.99 | 0.98 | 0.86 | 0.94 |
13 | 0.42 | 1.02 | 2.08 | 1.17 |
14 | 0.63 | 0.59 | 0.67 | 0.63 |
16 | 1.09 | 1.06 | 1.20 | 1.12 |
17 | 0.54 | 1.50 | 2.15 | 1.40 |
19 | 0.90 | 0.63 | 0.44 | 0.66 |
20 | 0.52 | 0.25 | 0.34 | 0.37 |
21 | 0.44 | 0.58 | 0.80 | 0.61 |
22 | 0.90 | 0.65 | 0.42 | 0.66 |
24 | 0.90 | 0.75 | 0.65 | 0.77 |
25 | 0.67 | 0.57 | 0.57 | 0.60 |
26 | 1.12 | 1.01 | 0.99 | 1.04 |
28 | 0.60 | 0.81 | 0.88 | 0.76 |
29 | 0.88 | 0.92 | 0.95 | 0.92 |
ED indicates effect dose.
The averaged combination index (CI) values were calculated from ED50, ED75, and ED90.